Skip to main content
Article
Conventional Anti-CD45 Radioimmunotherapy Comparing 90Y or 177Lu for Treatment of AML in a Syngeneic Disseminated Murine Leukemia Model,
Blood (2011)
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Aimee Kenoyer, Fred Hutchinson Cancer Research Center
  • Amanda Axtman, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Paul J. Morris, Fred Hutchinson Cancer Research Center
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Ted Gooley, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
November 18, 2011
Citation Information
Johnnie J. Orozco, Aimee Kenoyer, Amanda Axtman, Shani L. Frayo, et al.. "Conventional Anti-CD45 Radioimmunotherapy Comparing 90Y or 177Lu for Treatment of AML in a Syngeneic Disseminated Murine Leukemia Model," Blood Vol. 118 Iss. 21 (2011) p. 3636 - 3636
Available at: http://works.bepress.com/john-pagel/167/